Claritas Pharmaceuticals, Inc. (CLAZF)

OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Feb 27, 2026
0.00%
Market Cap 38.00
Revenue (ttm) n/a
Net Income (ttm) -4.72M
Shares Out 37.79M
EPS (ttm) -0.13
PE Ratio 0.00
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 22,203
Average Volume 2,701
Open 0.0000
Previous Close n/a
Day's Range 0.0000 - 0.0000
52-Week Range 0.0000 - 0.0000
Beta 38.61
RSI 45.58
Earnings Date n/a

About Claritas Pharmaceuticals

Claritas Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs. The company was formerly known as Kalytera Therapeutics, Inc. and changed its name to Claritas Pharmaceuticals, Inc. in April 2021. Claritas Pharmaceuticals, Inc. was founded in 2014 and is based in San Rafael, California. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Country Canada
Stock Exchange OTCMKTS
Ticker Symbol CLAZF
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.